| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Abeta42|Amyloid-beta protein 42|Beta-APP42 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human Aβ42 (Amyloid Beta 42) is a molecular target commonly studied in neuroscience research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of Aβ42 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of Aβ42 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
Aβ42 (Amyloid Beta 42) may also be referenced as Abeta42, Amyloid-beta protein 42, and Beta-APP42 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how Aβ42 relates to neuronal signaling and synaptic function, neuroinflammation, neurodegeneration models, and brain–body communication in neuroscience research.
- Interpreting shifts in Aβ42 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
Aβ42 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with neuroscience studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Correlation Between Brain Structure Atrophy and Plasma Amyloid-β and Phosphorylated Tau in Patients With Alzheimer’s Disease and Amnestic Mild Cognitive Impairment Explored by Surface-Based Morphometry
IF: 5.75 Journal: Frontiers in Aging Neuroscience Cited Date: 2022-05-20
Neurotoxic effects of coronavirus: Potential implications in Alzheimer's onset and progression
IF: 4.6 Journal: Experimental Neurology Author: Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena 41125, Italy. Cited Date: 2024-08-09
Sera miR-34a, miR-29b and miR-181c as potential novel diagnostic biomarker panel for Alzheimers in the Egyptian population
IF: 4.253 Journal: Experimental Gerontology Cited Date: 2023-04-14
Volume changes of hippocampal and amygdala subfields in patients with mild cognitive impairment and Alzheimer's disease
IF: 2.471 Journal: Acta Neurologica Belgica Cited Date: 2023-04-21
Plasma pTau181 and Neuropsychiatric Symptoms in Alzheimer's Dementia: Insights from a Cross-Sectional Study
IF: Journal: Journal of Pharmaceutical and Sciences Author: Department of Neurology, Faculty of Medicine, Universitas Andalas, Padang, West Sumatra, Indonesia. Cited Date: 2025-11-14